Inspired: WCG partners with health care social network to bolster clinical trial recruitment

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/cofotoisme)
(Image: Getty/cofotoisme)
WCG is partnering with Inspire, an online community of patients and caregivers, to connect research sponsors with potential clinical trial participants.

The WIRB-Copernicus Group’s (WCG) ​Clinical Services Division yesterday announced its partnership with Inspire, which has 1.5m members and 10m active annual users across 225 individual communities representing more than 3,600 discrete medical conditions. The news comes on the heels of a partnership with InformedDNA​ to support clinical trials using genetics.

“WCG and Inspire both recognize the critical role that patients play in advancing medical progress,”​ said Donald A. Deieso, PhD, executive chairman and chief executive officer, WCG.

Through its partnership with Inspire, Deieso said it is “making it easier for patients to access cutting-edge treatments by helping them identify relevant clinical trial opportunities.” ​Additionally, he noted that it also will make it easier for researchers to locate hard-to-find patients interested in participating in research.

“By adding Inspire to WCG’s already robust patient engagement platform, we’re enabling research sponsors to connect directly and more effectively with potential research volunteers, making clinical trials more patient-centric and ultimately accelerating the development of life-changing therapies to the patients who need them,”​ Deieso told us.

The companies will use permission-based and opt-in approaches to connect patients with clinical trial opportunities. As the Inspire network grows – membership to which is open to patients, caregivers, and providers across all therapeutic areas – Dieso said the company has an opportunity to serve each community, among new ones.

“WCG has a number of resources to share with Inspire community members, including the guidance of genetic specialists and counselors through our partnership with InformedDNA,”​ he said. “WCG and Inspire are committed to empowering patients by giving them greater access to educational resources and clinical trial opportunities.”

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars